Shares Plunge 15% as Retail Pharmacy Giant Focuses on Turnaround
Walgreens Boots Alliance (WBD) saw its stock tumble 15% on Friday after announcing the suspension of its quarterly dividend, ending a 92-year streak of payouts. The move is part of the company’s broader strategy to conserve cash, reduce debt, and improve free cash flow amid ongoing financial struggles.
The pharmacy chain cited “cash needs over the next several years,” including litigation expenses and debt obligations, as key factors in the decision. Walgreens had already cut its dividend in early 2024, reducing it to $0.25 per share.
Analysts viewed the suspension as a necessary step, despite potential short-term selling pressure. Leerink Partners’ Michael Cherny called the move “prudent and somewhat overdue,” while Evercore ISI’s Elizabeth Anderson estimated that the decision could save Walgreens around $650 million in fiscal 2025.
The dividend is unlikely to return until Walgreens stabilizes its U.S. pharmacy operations, offloads certain healthcare assets, and gains clarity on potential government-related financial obligations, according to Bloomberg Intelligence analyst Jonathan Palmer.
The company continues to face challenges, including declining pharmacy reimbursements and rising competition from online retailers. Amid cost-cutting measures and store closures, Walgreens is reportedly in talks with private equity firm Sycamore Partners for a potential buyout.
Despite gaining 23% this year through January 30, Walgreens shares had fallen 64% in 2024. The latest dividend suspension underscores the retailer’s ongoing struggle to regain financial stability and investor confidence.
You might like this article: MicroStrategy Raises $563M to Fuel Bitcoin Purchases
